期刊文献+

术前应用rhuEPO复合急性等容血液稀释对氧平衡的影响

Effects of preoperative rhuEPO therapy coupled with acute normovolemic hemodilution on oxygen balance in anesthetized dogs
下载PDF
导出
摘要 目的通过术前应用人工促红细胞生成素 (rhuEPO)对犬急性等容血液稀释时氧供需平衡的影响 ,探讨有效和安全的血液保护措施。方法 16条健康土种犬随机分配为单纯急性等容血液稀释 (ANH)组 (对照组 )和EPO +ANH组 (实验组 )。实验组在术前第 15、11、8、4d及手术当天 ,皮下注射rhuEPO 5 0 0IU/kg并口服铁剂。两组均实施三个步骤的等容血液稀释 ,每次放血 15mL/kg ,总计 4 5mL/kg ,予 6 %低分子右旋糖酐加以替代。结果稀释当天 ,实验组Hct升至 0 .6 3,明显高于对照组 (P <0 .0 5 )。 3次稀释后 ,实验组的Hct和动脉氧含量高于对照组 ,而氧摄取和心排量上升幅度较对照组低。结论EPO能增加机体的氧储备 ,用药后再进行血液稀释对机体氧平衡无明显影响 。 Objective To evaluate the efficacy and safety of EPO coupled with acute normovolemic hemodilution (ANH) to avoid allogenetic blood transfusion. Methods Sixteen dogs were randomly assigned to two groups, ANH group and rhuEPO plus ANH group (preoperative subcutaneous administration of 500 IU/kg rhuEPO at 15, 11, 8,4, 0 d before surgery followed by ANH in the operating room). All dogs underwent 3 step ANH, each step 15 mL/kg blood were removed from the dog, and replaced with equal volume of dextran 40. Results On the day of surgery hematocrit increased to 0.63 in EPO group (P<0.05). After 3 steps ANH, the rhuEPO coupled with ANH group had significantly higher level of hematocrit and arterial oxygen content compared with the other group. CO increased in the two groups, but in the control group the increasing of CO was insufficient to offset the decrease of oxygen content, so we can see an increase in EO 2. Conclusion The oxygen delivery is much better in the EPO coupled with ANH group than in the other group, and it is safe for futher hemodilution.
作者 朱莹 朱也森
出处 《上海第二医科大学学报》 CSCD 2004年第11期901-904,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 人工重组促红细胞生成素 急性等容血液稀释 氧供需平衡 血液保护 recombined human erythropoietin acute nomovolemic hemodilution oxygen balance
  • 相关文献

参考文献10

  • 1Zauder HL,Stehling L.Acute normovolaemic haemodilution[J].J Clin Anesth,2000,12(6):498.
  • 2LawrenceT,Goodnough,MD,Terri G,et al.Erythropoietion therapy in the perioperative setting[J].Clinic Orthipaedics,1999,357:82-88.
  • 3Neumeister MW,Li G,Williams G,et al.Factors in fluencing MAC reduction after cardiopulmonary bypass in dogs [J].Can J Anaesth,1997,44(10):1 120-1 126.
  • 4Randolph JF,Stokol T,Scarlett JM,et al.Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs[J].Am J Vet Res,1999,60(5):636-642.
  • 5Vaziri ND.Cardiovascular effects of erythropoietin and anemia correction [J].Curr Opin Nephrol Hypertens,2001,10(5):633-637.
  • 6Bode-Boger SM,Boger RH,Kuhn M,et al.Recombinant human erythropoetin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids [J].Kidney Int,1996,50(4):1 255-1 261.
  • 7D'Ambra MN,Gray RJ,Hillman R,et al.Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients [J].Ann Thorac Surg,1997,64:1 686-1 693.
  • 8Ickx BE,Rigolet M,van der Linden PJ,et al.Cardiovascularand metabolic respose to acute mormovolemic anemia,effects of anesthesia [J].Anesthesiology,2000,93(4):1 011-1 016.
  • 9Habler OP,Kleen MS,Hutter JW,et al.Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs [J].Transfusion,1998,38:135-143.
  • 10Sowade O,Warnke H,Scigalla P,et al.Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patient undergoing open-heart surger[J].Blood,1997,89:411-418.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部